{"id":"450afc1ddd25","type":"article","url":"https://hartvaat.nl/2020/08/01/raas-remmers-en-covid-19-mortaliteit-bij-hypertensie-meta-analyse/","title":"RAAS-remmers en COVID-19 mortaliteit bij hypertensie: meta-analyse","title_en":"Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.","category":"hypertensie","category_label":"Hypertensie","professions":["cardioloog","huisarts","internist"],"tags":["covid-hart","ras-remmers"],"journal":"Hypertension (Dallas, Tex. : 1979)","doi":"10.1161/HYPERTENSIONAHA.120.15572","source_url":"https://doi.org/10.1161/HYPERTENSIONAHA.120.15572","authors":["Xiaoming Guo","Yueli Zhu","Yuan Hong"],"significance":7,"published":"2020-08-01","source_date":"2020-08-01","image":"","kennis":["https://hartvaat.nl/kennis/farmacologie/aldosteron-en-raas-farmacologie/","https://hartvaat.nl/kennis/hypertensie/ace-remmers-hypertensie/"],"congress":"","summary_en":"This meta-analysis showed that RAAS inhibitor therapy is associated with decreased COVID-19 mortality in hypertensive patients, providing reassurance against the early pandemic concern that ACE inhibitors and ARBs might worsen SARS-CoV-2 outcomes.","created":"2026-07-03T10:28:41Z","updated":"2026-07-03T13:27:51Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Meta-analyse die verminderde COVID-19 mortaliteit aantoonde met RAAS-remmers bij hypertensieve patiënten. Geruststellend voor voortzetting van ACE-remmers/ARB's.","abstract_original":""}